HomeTagsOffshore

offshore

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
spot_img
SGX-LISTED COMPANIES

Why Beng Kuang Marine Could Surprise Investors In 2026

Why the "Boring" Side of Energy is Winning The offshore oil and gas sector has...
SGX-LISTED COMPANIES

Seatrium FY2025 Profits Double via Series Build Strategy

https://open.spotify.com/episode/4WSi7kfwIf0k3vqXAcI9vf?si=c5d5d5af831745db The $11.5 Billion Turnaround: 5 Surprising Takeaways from Seatrium’s Record-Breaking 2025 Industrial mega-mergers are notoriously...
SGX-LISTED COMPANIES

Why The World’s Geriatric Fleet Is Nam Cheong’s Secret Weapon

Unlocking the OSV Cycle For more than a decade, the offshore support vessel (OSV) industry...
SGX-LISTED COMPANIES

Why The ‘Boring’ Engineering Of Nordic Group Is The Smartest Play Of 2026

The 37% Upside Hiding in Plain Sight In an era of fragmenting global trade and...
SGX-LISTED COMPANIES

Is ASL Marine Shifting From Surviving To Thriving?

When most investors think about a thriving marine company, they picture massive shipyards launching...
SGX-LISTED COMPANIES

Nam Cheong’s Q3 2025 80% Profit Collapse Explained

Nam Cheong’s 80% Profit Plunge: Four Reasons It’s Actually Great News Introduction: Buried within the tables...

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...